Home » Topics » Asia-Pacific » Australia

Australia
RSS

Australia ramps up efforts to fight coronavirus with genetic sequence in hand

February 18, 2020

PERTH, Australia – As of Feb. 12, Australia’s Department of Health confirmed 15 cases of novel coronavirus in Australia.

Surgeons come together to create Field Orthopaedics to address market shortcomings

February 14, 2020

By Tamra Sami

No Comments

PERTH, Australia – Brisbane, Australia-based Field Orthopaedics was formed when a group of orthopedic surgeons were exasperated by ongoing shortcomings in surgical practice and decided to do something about it.

Australia ramps up efforts to fight coronavirus with genetic sequence in hand

February 12, 2020

By Tamra Sami

No Comments

PERTH, Australia – As of Feb. 12, Australia’s Department of Health confirmed 15 cases of novel coronavirus in Australia (five in Queensland, four in New South Wales, four in Victoria and two in South Australia). Of the confirmed 15 cases, five people have recovered and the others are in stable condition.

Australia’s Mesoblast submits final module of rolling BLA submission for pediatric GVHD stem cell therapy

February 4, 2020

By Tamra Sami

No Comments

PERTH, Australia – Mesoblast Ltd. has filed the final module of its rolling BLA submission for its allogeneic mesenchymal precursor cell therapy, remestemcel-L, after it showed strong survival rates in children with acute steroid-refractory graft-vs.-host disease (aGVHD).

Australia’s TGA proposes fee increases to implement recent drug, device reforms

January 28, 2020

By Tamra Sami

No Comments

PERTH, Australia – Australia’s Therapeutic Goods Administration (TGA) is seeking input from industry stakeholders on a proposal to increase its fees to cover projected deficits this year.

Bringing glaucoma risk into focus

Multitrait analysis predicts glaucoma susceptibility, progression

January 28, 2020

By John Fox

No Comments

An international collaborative study led by geneticists at the Queensland Institute of Medical Research Berghofer Medical Research Institute (QIMR) in Brisbane, Australia, has used a multivariate approach to develop a polygenic risk score (PRS) for glaucoma.

Bringing glaucoma risk into focus

Multitrait analysis predicts glaucoma susceptibility, progression

January 24, 2020

By John Fox

No Comments

Australia’s TGA proposes fee increases to implement recent drug, device reforms

January 24, 2020

By Tamra Sami

No Comments

PERTH, Australia – Australia’s Therapeutic Goods Administration (TGA) is seeking input from industry stakeholders on a proposal to increase its fees to cover projected deficits this year. The proposal outlines three options.

Australia’s TGA proposes fee increases to implement recent drug, device reforms

January 23, 2020

By Tamra Sami

No Comments

Noxopharm spin-off Nyrada lists on ASX raising AU$8.5 million in oversubscribed IPO

January 21, 2020

By Tamra Sami

No Comments

PERTH, Australia – Sydney-based Noxopharm Ltd. announced that its spin-off, Nyrada Inc., began trading on Australia’s Securities Exchange (ASX:NYR) on Jan. 16, following an oversubscribed IPO that raised AU$8.5 million (US$5.8 million).

South Korea approves first four COVID-19 test kits under urgent-use license
BioWorld
HONG KONG – South Korea’s Ministry of Food and Drug Safety (MFDS) recently granted the first urgent-use licenses to four COVID-19 novel coronavirus diagnostic...
Two South Korean COVID-19 kits look overseas, seek FDA approval
BioWorld MedTech
HONG KONG – As the number of COVID-19 confirmed cases and deaths continue to rise globally, South Korea’s focus on testing has attracted international attention....
Noninvasive ventilation options explored for COVID-19, as FDA eases with guidance
BioWorld MedTech
Like so many other ventilator providers in recent days, Resmed Inc. has committed to ramping up production. It aims to triple its ventilator output and multiply...
FDA says yes to NO: Bellerophon Therapeutics wins expanded access approval for inhaled nitric oxide system
BioWorld
DUBLIN—Can high-dose inhaled nitric oxide (NO) make a meaningful contribution to patients with COVID-19 infection? The FDA was sufficiently persuaded by the data...
Antiviral favipiravir effective against COVID-19, China says
BioWorld
Randomized trials of the broad-spectrum antiviral favipiravir, marketed as an anti-influenza treatment by Fujifilm Holdings Corp., have shown "obvious efficacy"...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Australia RSS

Popular Stories

BioWorld Premium

Australia
RSS